2006
Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia. Arch Pathol Lab Med. 2006;130(7):1075-6.
Hydration of the folding transition state ensemble of a protein. Biochemistry. 2006;45(11):3473-80.
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood. 2006;107(2):689-97.
Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol. 2006;19 Suppl 2:S71-87.
NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood. 2006;107(8):3295-302.
Defining cell lineages in the prostate epithelium. Cell Cycle. 2006;5(2):138-41.
Lung transplantation: opportunities for research and clinical advancement. Am J Respir Crit Care Med. 2006;173(4):466-7; author reply 467.
Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol. 2006;28(5):399-409.
Pathology of B-cell non-Hodgkin's lymphomas and multiple myeloma. Cancer Treat Res. 2006;131:1-48.
